Intellectual Human Capital and the Birth of US Biotechnology Enterprises

Clicks: 3
ID: 291624
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #847 of 1,518 articles by views in Oxford University Press eBooks

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,518 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract The number of American firms actively using biotechnology grew rapidly from nonexistent to over 700 in less than two decades, transforming the nature of the pharmaceutical industry and significantly impacting food processing, brewing, and agriculture, as well as other industries. Here we demonstrate empirically that the commercialization of this technology is essentially intertwined with the development of the underlying science in a way which illustrates the significance in practice of the localized spillovers concept in the agglomeration literature and of the tacit knowledge concept in the information literature.
Reference Key
openalex_W3121527737 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lynne G. Zucker, Michael R. Darby, Marilynn B. Brewer
Journal Oxford University Press eBooks
Year 2003
DOI
10.1093/oso/9780199256938.003.0008
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.